The Microcap Newsletter
  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference
Free Sign Up
Attend The Microcap Conference
No Result
View All Result
The Microcap Newsletter
  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference
Free Sign Up
Attend The Microcap Conference
No Result
View All Result
The Microcap Newsletter
No Result
View All Result

A Deuce of Microcap IPOs Kicks Off 2024

January 1, 2024

The microcap IPO flow is more of a trickle in the first week of 2024 with just two companies on the calendar.

However, recent reports reveal an optimistic outlook for 2024, with predictions that the S&P 500 would jump by nearly 25% to reach between 4,750 and 4,800 by year-end.

This week the floats include a holding company incorporated in the Cayman Islands with operations in China for an automotive mold developer and supplier, and a social good organization providing a free care communication platform offering low-cost patient education resources from nonprofit, government, and commercial organizations.

Mingteng International (MTEN) has an estimated IPO date of Dec. 29, intending to raise around $11 million at a $35 million market cap. Now, the company has an estimated IPO date of Jan. 2 and is still seeking to raise $11 million at the $35 million cap.

Docola (DOCO) had estimated IPO dates of Nov. 21, Dec. 5, Dec. 20, and Dec. 27, aiming to raise nearly $7 million at about a $31 million market cap. Now, the company has an estimated IPO date of Jan. 5 and still intends to raise almost $7 million at the same market cap.

Recent Posts

Bi-Monthly Report on SEC Oversight of Penny Stock Violations

SEC: Unregistered Dealer Profits from Distressed Penny-Stock Sales

March 11, 2024
Microcap IPO Flow Remains Strong into September

Microcap IPO Flow Holds Steady into Mid-March

March 11, 2024
Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts

Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts

March 11, 2024
DealFlow Events logo

PO Box 122
Syosset, NY 11791
(516) 876-8006
team@dealflowevents.com

Twitter

Subscribe to our free newsletter

Stay informed on the latest weekly Microcap news.

SIGN UP

Sponsored content, this is a paid promotion

Comments and opinions presented in DealFlow Events publications such as The Microcap Newsletter are solely those of the analysts, corporate executives, and others quoted. They do not represent the opinions of DealFlow Events and DealFlow Events makes no recommendations on whether to buy, sell or hold shares of any particular stock. Investors are advised to conduct their own research before making an investment decision. Neither DealFlow Events nor any of its affiliates hold any position in the stocks mentioned in The Microcap Newsletter.

© DealFlow Financial Products, Inc. (d/b/a DealFlow Events). All rights reserved. DealFlow Events™ and The Microcap Conference™ and The Microcap Newsletter™ are trademarks of DealFlow Financial Products, Inc.

  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference